Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy
- Rebecca M. Minter*,
- Maria A. Ferry*,
- John E. Rectenwald*,
- F. R. Bahjat*,
- Andreas Oberholzer*,
- Caroline Oberholzer*,
- Drake La Face†,
- Van Tsai†,
- C. M. Iqbal Ahmed†,
- Beth Hutchins†,
- Edward M. Copeland III*,
- Harold S. Ginsberg‡,§, and
- Lyle L. Moldawer*,¶
- *Department of Surgery, University of Florida College of Medicine, P.O. Box 100286, Gainesville, FL 32610; †Canji, Inc., San Diego, CA 92121; and ‡National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852
-
Contributed by Harold S. Ginsberg
Abstract
IL-10 is a pleiotropic cytokine that acts as an important regulator of macrophage, T cell, and natural killer cell functions. Human IL-10 (hIL-10) has both stimulatory and inhibitory effects on a wide variety of cell types. Viral IL-10 (vIL-10) possesses only a subset of hIL-10's activities, predominantly its suppression of cytokine synthesis by T helper type 1 clones. In the present report, we evaluated tissue accumulation and biological activity of hIL-10 and vIL-10 in vivo in individual organs by using a first-generation adenoviral (Ad) vector administered intratracheally and intravenously. We report the observation that Ad vectors delivering vIL-10, but not hIL-10, are associated with prolonged expression in the lung (>42 days) when delivered intratracheally. In contrast, there was no prolongation in vIL-10 expression when Ad vectors were intravenously administered, although vIL-10 levels in the tissue, but not serum, were markedly increased relative to hIL-10. Moreover, we report an augmented capacity of expressed vIL-10 versus hIL-10 to suppress the acute inflammatory responses in the lung to intratracheal administration of Ad. These findings confirm fundamental differences in Ad-induced expression of vIL-10 and hIL-10 when administered to the lungs. The results further suggest that Ad vectors expressing vIL-10 may have a role as anti-inflammatory agents in the treatment of acute and chronic lung inflammation.
Footnotes
-
↵ § Present address: 19 Proctor Road, Woods Hole, MA 02543-1534.
-
↵ ¶ To whom reprint requests should be addressed at: Department of Surgery, Room 6116, Shands Hospital, University of Florida College of Medicine, Gainesville, FL 32610. E-mail: moldawer{at}surgery.ufl.edu.
-
Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.250489297.
-
Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.250489297
- Abbreviations:
- Ad,
- adenovirus or adenoviral;
- β-gal,
- β-galactosidase;
- TNF-α,
- tumor necrosis factor α;
- IL-1α,
- interleukin 1α;
- hIL-10,
- human IL-10;
- cIL-10,
- cellular IL-10;
- vIL-10,
- viral IL-10;
- i.t.,
- intratracheal(ly);
- i.v.,
- intravenous(ly)
- Copyright © 2001, The National Academy of Sciences





